Clinical trialNCT07225842RecruitingPhase 4Interventional

The Bridging Antiplatelet Therapy With Cangrelor 2 Study

SponsorUniversity of FloridaEnrollment50Coronary Arterial Disease (CAD)

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The primary aim of this study is to determine rates of patients with optimal platelet reactivity range, defined as PRU levels between 85 and 208, when using a (PFT)-guided titration of cangrelor infusion rate (cangrelor titration) compared to 0.75 mcg/kg/min (standard-dose infusion) for bridging.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Dominick J Angiolillo, MD, PhD
University of Florida College of Medicine - Jacksonville
Study ChairKOL profile →
clinicaltrials.gov ↗
Luis Ortegra-Paz, MD, PhD
University of Florida College of Medicine - Jacksonville
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of Florida Jacksonville
Jacksonville, Florida, United States
Luis Ortega, MD, PhD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Cangrelor →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 18 Feb 2026
Primary completion: 30 Sept 2027
Completion: 30 Nov 2027
Last update posted: 5 May 2026
Registered enrollment: 50
Registry id: NCT07225842

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.